Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Condition:   Psoriasis Interventions:   Drug: PF-06763809;   Other: Vehicle;   Drug: Calcipotriene/calcipotriol;   Drug: Betamethasone Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials